Here you will find copies of all the ASX Announcements made by Bio-Gene (ASX:BGT) since its listing on 29 November 2017 to 31 December 2018
13-12-2018 BIO-GENE EXPANDS RESEARCH PROGRAM FOR QCIDE™
06-12-2018 Change of Director's Interest - P May
06-12-2018 Change of Director's Interest - R Jagger
06-12-2018 Appendix 3B
21-11-2018 Expiry of Listed Options
20-11-2018 2018 AGM - Results of Meeting
20-11-2018 2018 AGM - CEO Presentation
25-10-2018 Appendix 4C - 30 September 2018
16-10-2018 Notice of Annual General Meeting/Proxy Form
15-10-2018 Change of Registered Office
15-10-2018 Company Update Presentation
11-10-2018 LATEST RESEARCH PROJECT IMPROVES MANUFACTURING PROCESS FOR FLAVOCIDE™
09-10-2018 POSITIVE RESULTS FROM 28-DAY TOXICOLOGY STUDY ON FLAVOCIDE™
02-10-2018 Appendix 3B
28-09-2018 Change of Registry Address - Automic Pty Ltd
14-09-2018 Upcoming Release of Share from Escrow
12-09-2018 POSITIVE RESULTS FOR FLAVOCIDE™ IN INITIAL FIELD TESTING
05-09-2018 POSITIVE EFFICACY RESULTS FOR FLAVOCIDE™ IN NEW PEST TYPES
23-08-2018 BGT 2018 Corporate Governance Statement
23-08-2018 Appendix 4G - 2018
23-08-2018 Appendix 4E and Annual Report - 30 June 2018
26-07-2018 Appendix 3B
26-07-2018 Appendix 4C - 30 June 2018
23-07-2018 POSITIVE RESULTS FOR FLAVOCIDE IN SAFETY STUDY FOR BENEFICIAL INSECTS
10-07-2018 BIO-GENE SUBMITS TWO NEW INTERNATIONAL PATENT APPLICATIONS
03-07-2018 QCIDE PERSONAL INSECT REPELLENT FORMULATIONS SHOWN TO BE HIGHLY EFFECTIVE IN FIRST HUMAN EXPOSURE TESTS. EXPANSION OF TREE DEVELOPMENT PROGRAM FOR QCIDE OIL PRODUCTION
29-06-2018 Upcoming Release of Share from Escrow
29-06-2018 Appendix 3B
26-06-2018 EXPANSION OF FLAVOCIDE MODE OF ACTION STUDIES
18-06-2018 BEE SAFETY STUDY DELIVERS POSITIVE FINDINGS FOR FLAVOCIDE™
13-06-2018 Upcoming Release of Share from Escrow
28-05-2018 POSITIVE RESULTS WITH FLAVOCIDE™ VS. GRAIN STORAGE PESTS
11-05-2018 Upcoming Release of Share from Escrow
30-04-2018 APPENDIX 4C - 31 MARCH 2018
26-04-2018 POSITIVE RESULTS IN EFFICACY TEST WITH FLAVOCIDE™ AGAINST ANOTHER MAJOR AGRICULTURAL PEST
17-04-2018 MANUFACTURING DEVELOPMENT PROJECT WITH CSIRO ADVANCES TO STAGE 3
09-04-2018 POSITIVE RESULTS IN EFFICACY TEST FOR FLAVOCIDE™ WITH MAJOR CEREAL CROP PEST
27-03-2018 Appendix 3B
26-03-2018 POSITIVE RESULTS IN EFFICACY TEST FOR FLAVOCIDE™ WITH MAJOR RICE PEST
23-03-2018 Bio-Gene Investor Conference Call - 26 March 2018
21-03-2018 ANIMAL HEALTH TESTING AND COLLABORATION UPDATE
08-03-2018 Appendix 3B
07-03-2018 Upcoming Release of Shares from Escrow
01-03-2018 Prospectus for Loyalty Options Lodged
01-03-2018 Letter to Optionholders
01-03-2018 Letter to Ineligible Shareholders
01-03-2018 Appendix 3B
01-03-2018 Prospectus for Loyalty Options
23-02-2018 Appendix 3B
20-02-2018 Loyalty Options Update
14-02-2018 KEY APPOINTMENTS TO ADVISORY & MANAGEMENT TEAMS
08-02-2018 Appendix 4D - Half Year Report - 31 December 2017
06-02-2018 Upcoming Release of Shares from Escrow
31-01-2018 PILOT STUDY SHOWS FLAVOCIDE™ ACTIVITY AGAINST SUSCEPTIBLE AND RESISTANT MOSQUITOS
30-01-2018 Appendix 4C - December 2017
21-12-2017 BIO-GENE – 2018 GOALS AND OBJECTIVES FOLLOWING SUCCESSFUL IPO
19-12-2017 BIO-GENE ANNOUNCES POSITIVE SAFETY RESULTS
11-12-2017 BIO-GENE REPORTS POSITIVE INITIAL EFFICACY RESULTS
04-12-2017 Appendix 3B
04-12-2017 BIO-GENE APPOINTS MR DOUG RATHBONE AS AN ADVISOR
01-12-2017 BIO-GENE EXTENDS RESEARCH COLLABORATION WITH QDAF
30-11-2017 BIO-GENE EXTENDS RESEARCH COLLABORATION WITH CSIRO
29-11-2017 BIO-GENE COMPLETES $7.1M IPO TO LIST ON ASX
29-11-2017 Becoming a Substantial Shareholder
29-11-2017 Bio-Gene Investor Briefing
29-11-2017 Initial Director's Interest Notice - P May
29-11-2017 Initial Director's Interest Notice - K Rumble
29-11-2017 Initial Director's Interest Notice - R Klupacs
29-11-2017 Initial Director's Interest Notice - R Jagger
29-11-2017 Initial Director's Interest Notice - D Brumley
For All Pre- Listing Announcements Please Refer to the ASX Website Here
To be alerted about our ASX Announcements and other news on Bio-Gene you can join our mailing list here: